Full Event Guide

With 25+ expert speakers, 20+ dedicated sessions, and two pre-conference workshops, this is the only opportunity for drug developers to learn how to accelerate the development of novel anti-VEGF and VEGF-independent therapies and drug delivery options to reduce clinical burden, widen therapeutic index and treatment options for non-responders .

Join our speakers from AsclepiX Therapeutics, REGENEXBio, Apellis, Roche, Novartis, Genentech and more with exciting networking opportunities, panel discussions and dedicated case studies. Find full details in the 2022 event brochure.

Wet AMD Full event guide

Having trouble downloading the brochure? Let us know here and we’ll email it to you instead

Download the full program to find out more including these highlights:

Get up to speed with how the industry is improving the efficacy and durability of VEGF therapeutics

Uncover real life case studies including novel targets driving wet AMD & DME

Evaluate the latest drug delivery mechanisms and routes of administration to reduce treatment burden for Wet AMD and DME patients

Join expert speakers, including:
Outlook Therapeutics
Roche
Apellis
New England Retina Associates
Jassen

Join expert speakers, including:
Novartis
Isarna Therapeutics
OcuTerra
Surrozen

Join expert speakers, including:
SparingVision
Clearside Bio
Genentech
OcuTerra
REGENEXBio
eLCON Medical
GreyBug Vision
Occuphire